MetLife, Inc.
MET
$70.57
-$1.33-1.85%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 18.84B | 17.18B | 17.68B | 15.48B | 15.63B |
| Total Other Revenue | 189.00M | -1.31B | -1.05B | -91.00M | -30.00M |
| Total Revenue | 19.02B | 15.87B | 16.62B | 15.39B | 15.60B |
| Cost of Revenue | 13.35B | 12.92B | 13.88B | 11.89B | 7.34B |
| Gross Profit | 5.68B | 2.94B | 2.75B | 3.50B | 8.26B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.05B | 2.94B | 2.88B | 2.80B | 2.83B |
| Total Operating Expenses | 16.39B | 15.86B | 16.75B | 14.69B | 10.17B |
| Operating Income | 2.63B | 2.00M | -131.00M | 700.00M | 5.43B |
| Income Before Tax | 941.00M | 534.00M | 430.00M | 257.00M | 2.03B |
| Income Tax Expenses | 327.00M | 39.00M | 22.00M | 172.00M | 445.00M |
| Earnings from Continuing Operations | 614.00M | 495.00M | 408.00M | 85.00M | 1.58B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.00M | -6.00M | -6.00M | -5.00M | -3.00M |
| Net Income | 607.00M | 489.00M | 402.00M | 80.00M | 1.58B |
| EBIT | 2.63B | 2.00M | -131.00M | 700.00M | 5.43B |
| EBITDA | 3.27B | 28.00M | -101.00M | 728.00M | 6.02B |
| EPS Basic | 0.78 | 0.56 | 0.48 | 0.02 | 1.98 |
| Normalized Basic EPS | 0.79 | 0.44 | 0.34 | 0.20 | 1.61 |
| EPS Diluted | 0.77 | 0.56 | 0.48 | 0.02 | 1.96 |
| Normalized Diluted EPS | 0.78 | 0.43 | 0.34 | 0.20 | 1.60 |
| Average Basic Shares Outstanding | 738.60M | 751.40M | 765.90M | 775.40M | 784.20M |
| Average Diluted Shares Outstanding | 743.40M | 755.50M | 769.60M | 781.20M | 790.20M |
| Dividend Per Share | 0.52 | 0.52 | 0.52 | 0.50 | 0.50 |
| Payout Ratio | 69.03% | 93.87% | 107.21% | 568.75% | 26.74% |
